Dec08Thu
Nov10Thu
IABCN Members, Pennsylvania Department of Community and Economic Development and Almac Group, have partnered to create 312 more jobs in Montgomery County
Reported by Philadelphia Business Journal
Almac Group Inc. is planning to add more than 300 jobs in Montgomery County over the next three years.
The global contract pharmaceutical development and manufacturing organization is expanding operations at its existing 240,000-square-foot U.S. headquarters in Souderton, and doubling its physical presence in Lansdale.
The Pennsylvania Department of Community and Economic Development is providing Almac with $1.56 million grant under the state’s Pennsylvania First Program to support the expansion. Read More
Nov10Thu
|
|
|
| Craigavon, N.I., 10th November 2016 – Almac Group, the global contract pharmaceutical development and manufacturing organisation is excited to announce ambitious plans to expand its operations in Europe and North America increasing its global headcount to reach 5,000 by 2017.As part of its ongoing global growth strategy and in response to increased client demand for its range of services the organisation will invest a further £20 million at Almac’s US headquarter site in Souderton, Pennsylvania to expand its existing 240,000-square-foot facility in addition to leasing a 26,000-square-foot office space in nearby Lansdale. Read More |
Irish early stage investment company Lucey Fund is looking for startups – November 4th!
The Lucey Fund is leading the wave of very early stage Tech Angel investing and have invested in 80+ startups in the past 3 years, 30 of which were in the past 12 months, with plans to make 50+ in 2016. We are seeking new investment opportunities at Venturef0rth, come meet the Founder Ian Lucey and tell us more about your startup!
At the meeting, Ian will share hints on how to manage finance, get funding and what is the first thing entrepreneurs should do when founding a startup.
Schedule of the event:
1:00 PM — 1:30 PM Gathering
1:30 PM — 2:15 PM Q&A with Ian Lucey
2:15 PM — 3:00 PM Networking
Register by clicking HERE.
ICON Announces Executive Leadership Transition
Mr. Ciaran Murray to transition to Chairman, effective 1st March 2017
Dr. Steve Cutler to be appointed Chief Executive Officer, effective 1st March 2017
Dublin, Ireland, October 20, 2016 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that, as part of its planned succession of executive leadership, Mr. Ciaran Murray will transition to the role of Chairman of the Board of Directors and Dr. Steve Cutler will be appointed as Chief Executive Officer, with both changes effective as of 1st March 2017.
View footage from the Global Interdependence Center’s Central Banking Series in Dublin, September 2016
